The Medical Marijuana – A Catalyst for Change in the Process of Alzheimer’s Prevention

The issue of medical Marijuana still represent a controversial topic. While many doctors are lobbying for an increased use in the medical world, other health specialists are opposed. Additionally, new studies constantly explore the drug as a potential treatment to chronic and mental problems. One important aspect is increased analysis related with the effects of medical marijuana on Alzheimer’s treatment and symptoms.

Click here for good Medicare Supplement Plans 2018 plans.

One notable, preclinical study published in the Journal of Alzheimer’s Disease found that very small doses of tetrahydrocannabinol (THC), a chemical element that is present in the marijuana,  have the ability to slow the production of beta-amyloid proteins. These beta-amyloid components are thought be key factor to the general progression of Alzheimer’s. Now, it is important to look at the bigger picture here. These findings should not be confused that the use of marijuana can regress the negative effects of Alzheimer, even though many scientists are trying to portray like that is the case. To be more specific, the findings of the these studies have pinpointed the specific components that can help in treating the disease. That means that a proper extraction of these chemicals may be the solution with the goal of creating a combined element that is safe and legal, which can can be the catalyst for change in the way we treat the disease. Researchers also state that their findings were done in a laboratory model and that further research needs to be done in a clinical trial before any conclusive evidence can be produced.

The second notable research was conducted by the Salk Institute labs in San Diego, California. Through this study, researchers were able to also find presence of the key component of tetrahydrocannabinol in the Marijuana while also confirming the theory on the effect on the amyloid and protecting the brain cells. Moreover, their findings include an effect in reducing cellular inflammation, a basic generator that speeds up the disease’s progression.

On the other side, there are many researchers that claim the evidence in the recent studies are not sufficient. According to the authors Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease the research studies so far have mostly offered little or of low amount of information thus making it challenging to come to an informed conclusion.

Nevertheless, there is increasing number evidence at laboratory level that specific elements of marijuana may have the potential to help regressing the process of Alzheimer disease. On the other side, we can agree that our research still lacks enough data about the potential benefits of cannabis in the managing process of the Alzheimer disease.

That is why, it is imperative to increase the research studies in order to find the right answers that can potentially have a galvanizing effect on the wellbeing of many people. In the same time, we need to remain humble and open minded about the potential of cannabis elements being used as a innovative medicine.

Comments are closed.